BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 10674012)

  • 1. Differential prognosis of replication error phenotype and loss of heterozygosity in sporadic colorectal cancer.
    Massa MJ; Iniesta P; González-Quevedo R; de Juan C; Caldés T; Sánchez-Pernaute A; Cerdán J; Torres AJ; Balibrea JL; Benito M
    Eur J Cancer; 1999 Nov; 35(12):1676-82. PubMed ID: 10674012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Replication error in colorectal carcinoma: association with loss of heterozygosity at mismatch repair loci and clinicopathological variables.
    Johannsdottir JT; Bergthorsson JT; Gretarsdottir S; Kristjansson AK; Ragnarsson G; Jonasson JG; Egilsson V; Ingvarsson S
    Anticancer Res; 1999; 19(3A):1821-6. PubMed ID: 10470121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between recurrence of sporadic colorectal cancer, high level of microsatellite instability, and loss of heterozygosity at chromosome 18q.
    Sarli L; Bottarelli L; Bader G; Iusco D; Pizzi S; Costi R; D'Adda T; Bertolani M; Roncoroni L; Bordi C
    Dis Colon Rectum; 2004 Sep; 47(9):1467-82. PubMed ID: 15486743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allelic loss on chromosome 18q as a prognostic marker in stage II colorectal cancer.
    Martínez-López E; Abad A; Font A; Monzó M; Ojanguren I; Pifarré A; Sánchez JJ; Martín C; Rosell R
    Gastroenterology; 1998 Jun; 114(6):1180-7. PubMed ID: 9609754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of heterozygosity at 3p23 is correlated with poor survival in patients with colorectal carcinoma.
    Iniesta P; Massa MJ; González-Quevedo R; de Juan C; Morán A; Sánchez-Pernaute A; Cerdán J; Torres A; Balibrea JL; Benito M
    Cancer; 2000 Sep; 89(6):1220-7. PubMed ID: 11002216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of replication errors on chromosomes 2p and 3p in non-small-cell lung cancer.
    Pifarré A; Rosell R; Monzó M; De Anta JM; Moreno I; Sánchez JJ; Ariza A; Mate JL; Martińez E; Sánchez M
    Br J Cancer; 1997; 75(2):184-9. PubMed ID: 9010024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allelic loss of a common microsatellite marker MYCL1: a useful prognostic factor of poor outcomes in colorectal cancer.
    Kambara T; Sharp GB; Nagasaka T; Takeda M; Sasamoto H; Nakagawa H; Isozaki H; MacPhee DG; Jass JR; Tanaka N; Matsubara N
    Clin Cancer Res; 2004 Mar; 10(5):1758-63. PubMed ID: 15014029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Analysis of microsatellite alteration in colorectal cancer].
    Mizunuma H; Takita K; Ooki S; Onda M; Ando Y; Yoshida T; Tsuchiya A; Abe R
    Gan To Kagaku Ryoho; 1998 Apr; 25 Suppl 3():443-9. PubMed ID: 9589050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of heterozygosity: an independent prognostic factor of colorectal cancer.
    Chang SC; Lin JK; Lin TC; Liang WY
    World J Gastroenterol; 2005 Feb; 11(6):778-84. PubMed ID: 15682467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromosome 8p alterations in sporadic and BRCA2 999del5 linked breast cancer.
    Sigbjörnsdottir BI; Ragnarsson G; Agnarsson BA; Huiping C; Barkardottir RB; Egilsson V; Ingvarsson S
    J Med Genet; 2000 May; 37(5):342-7. PubMed ID: 10807692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of the genetic pathways involved in the pathogenesis of three types of colorectal cancer.
    Tomlinson I; Ilyas M; Johnson V; Davies A; Clark G; Talbot I; Bodmer W
    J Pathol; 1998 Feb; 184(2):148-52. PubMed ID: 9602705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of the allelic loss of the BRCA1 gene in colorectal cancer.
    Garcia JM; Rodriguez R; Dominguez G; Silva JM; Provencio M; Silva J; Colmenarejo A; Millan I; Muñoz C; Salas C; Coca S; España P; Bonilla F
    Gut; 2003 Dec; 52(12):1756-63. PubMed ID: 14633957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RER and LOH association with sporadic colorectal cancer in Taiwanese patients.
    Tsai MH; Yang YC; Chen KH; Jiang JK; Chou SJ; Chiang TC; Jan HS; Lou MA
    Hepatogastroenterology; 2002; 49(45):672-7. PubMed ID: 12063967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distribution of genetic variants in preneoplastic areas of colorectal tumours.
    Lindforss U; Papadogiannakis N; Zetterquist H; Lindberg G; Olivecrona H
    Eur J Surg Oncol; 2003 Aug; 29(6):491-6. PubMed ID: 12875854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of losses of heterozygosity and replication errors in primary colorectal carcinomas and corresponding liver metastases.
    Bläker H; Graf M; Rieker RJ; Otto HF
    J Pathol; 1999 Jul; 188(3):258-62. PubMed ID: 10419592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic instability and alterations in Apc, Mcc and Dcc in Hong Kong patients with colorectal carcinoma.
    Ko JM; Cheung MH; Kwan MW; Wong CM; Lau KW; Tang CM; Lung ML
    Int J Cancer; 1999 Aug; 84(4):404-9. PubMed ID: 10404094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allelotype analysis of oesophageal adenocarcinoma: loss of heterozygosity occurs at multiple sites.
    Dolan K; Garde J; Gosney J; Sissons M; Wright T; Kingsnorth AN; Walker SJ; Sutton R; Meltzer SJ; Field JK
    Br J Cancer; 1998 Oct; 78(7):950-7. PubMed ID: 9764589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Esophageal squamous cell carcinomas with DNA replication errors (RER+) are associated with p16/pRb loss and wild-type p53.
    Mathew R; Arora S; Mathur M; Chattopadhyay TK; Ralhan R
    J Cancer Res Clin Oncol; 2001 Oct; 127(10):603-12. PubMed ID: 11599796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation analysis between loss of heterozygosity at chromosome 18q and prognosis in the stage-II colon cancer patients.
    Wang W; Li YF; Sun XW; Chen G; Zhan YQ; Huang CY; Wan DS; Pan ZZ; Zhou ZW
    Chin J Cancer; 2010 Aug; 29(8):761-7. PubMed ID: 20663324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 18q loss of heterozygosity in microsatellite stable colorectal cancer is correlated with CpG island methylator phenotype-negative (CIMP-0) and inversely with CIMP-low and CIMP-high.
    Ogino S; Kawasaki T; Kirkner GJ; Ohnishi M; Fuchs CS
    BMC Cancer; 2007 May; 7():72. PubMed ID: 17474983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.